Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
BBH
26
HOLDINGS
25%
ALSO IN CANC
CANC
55
HOLDINGS
11%
ALSO IN BBH
SECTOR DRIFT (BBH minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 4.8% | 6.6% | 4.8% |
|
AMGEN INC | 14.0% | 2.6% | 2.6% |
|
BEIGENE LTD. SPONSORED ADR | 2.0% | 1.2% | 1.2% |
|
GILEAD SCIENCES INC | 13.0% | 1.0% | 1.0% |
|
REGENERON PHARMACEUTICALS | 5.9% | 0.7% | 0.7% |
BBH Overweight Relative to CANC
|
GILEAD SCIENCES INC | 12.0% |
|
AMGEN INC | 11.4% |
|
VERTEX PHARMACEUTICALS INC | 8.2% |
 |
ARGENX SE ADR | 6.4% |
|
REGENERON PHARMACEUTICALS | 5.2% |
|
IQVIA HOLDINGS INC | 4.2% |
|
NATERA INC | 4.1% |
|
BIOGEN IDEC INC | 4.0% |
|
MODERNA, INC. | 3.9% |
|
ALNYLAM PHARMACEUTICALS INC | 3.5% |
BBH Underweight Relative to CANC
|
ELI LILLY & CO | -5.1% |
|
COGENT BIOSCIENCES INC | -4.4% |
 |
NOVARTIS AG | -4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.2% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.6% |
|
MERCK & CO. INC. | -3.5% |
|
IMMUNOME, INC. | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.4% |
|
NUVALENT, INC. CLASS A | -3.3% |
 |
ASTRAZENECA PLC | -3.1% |